Lingzhi Hong

21PUBLICATIONS
160CO-AUTHORS
Molecular targetsPredictive and prognostic markersCancer diagnosisElectrical energy generation (incl. renewables, excl. photovoltaics)Cancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (21)

|Jul 27, 2026
The genomic landscape and treatment outcomes associated with CDKN2A/MTAP loss in patients with non-small cell lung cancer.

|May 18, 2026
Clinical Outcomes and Predictors of Response to PD-(L)1 Blockade in Patients with NSCLC without Actionable Genomic Alterations Who Never Used Tobacco.

|Apr 23, 2026
Real-World Experience of Tarlatamab in Extensive-Stage Small Cell Lung Carcinoma Showed Promising Systemic and Intracranial Efficacy With Higher Neurologic Toxicity.

|Dec 11, 2025
MET Overexpression Is Associated with Superior Immunotherapy Benefit in Advanced Non-Small Cell Lung Cancer.

Hui Li, Lingzhi Hong, Pedro Rocha

|Nov 13, 2025
Radiomics for Dynamic Lung Cancer Risk Prediction in USPSTF-Ineligible Patients.

Morteza Salehjahromi, Hui Li, Eman Showkatian

|Sep 24, 2025
Poziotinib for EGFR exon 20-insertion NSCLC: Clinical efficacy of the phase 2 ZENITH trial and differential impact of EGFR exon 20 insertion location on sensitivity.

Xiuning Le, Jacqulyne P Robichaux, Monique Nilsson

Pageof 4

Frequent Collaborators

19 joint publications

Jianjun Zhang

14 joint publications

Xiuning Le

14 joint publications

Jia Wu

12 joint publications

John Victor Heymach